Clinical trial
Radiofrequency Ablation Followed By Hepatic Artery Chemotherapy in Treating…
NCT00004142 · M.D. Anderson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00004142 |
|---|---|
| Title | Radiofrequency Ablation Followed By Hepatic Artery Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver |
| Official title | Phase II Study of Radiofrequency Ablation of Colorectal Cancer Liver Metastases Combined With Post-Ablation Hepatic Arterial Infusion of Floxuridine Alternating With 5-Fluorouracil |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Cancer, Metastatic Cancer |
| Intervention type | Drug, Procedure |
| Interventions | Floxuridine, Fluorouracil (5-FU), Conventional surgery, Radiofrequency ablation |
| Enrollment | 40 |
| Start date | Aug 5, 1998 |
| Primary completion | Dec 9, 2003 |
| Completion | Dec 9, 2003 |
| First posted | Mar 15, 2004 |
| Last update posted | Oct 26, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: